BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 29, 2016
View Archived Issues
Researchers present phase Ib results on Lilly's taladegib for SCLC
Read More
Blueprint Medicines discloses preliminary first-in-human data of BLUE-285 in GIST patients
Read More
Ropeginterferon alfa-2b shows promise in patients with polycythemia vera
Read More
Investigators present phase II results on CTL-019 in ALL patients
Read More
Ascendance Biotechnology gains rights to GE Healthcare's Cytiva cardiomyocytes
Read More
Achillion Pharmaceuticals receives milestone payment for JNJ-4178
Read More
Vertex Pharmaceuticals patents triazoles for demyelinating diseases
Read More
Medshine Discovery discloses JAK inhibitors
Read More
Galena Biopharma gives update on regulatory plans for GALE-401
Read More
Syros Pharmaceuticals describes c-Myc inhibitors
Read More
Dana-Farber Cancer Institute develops SMO receptor antagonists
Read More
Chiesi Farmaceutici presents muscarinic M3 receptor antagonists and beta2-adrenoceptor agonists
Read More
Patient enrollment begins in phase I trial of TQ-B3395 in patients with advanced cancer
Read More
EMT gene expression as biomarkers in neuroendocrine lung carcinoma
Read More
Shire is enrolling patients in phase III trial of maribavir in transplant recipients
Read More
Bristol-Myers Squibb initiates phase II trial of BMS-986165
Read More
AstraZeneca initiates phase I trial of AZD-0284 for plaque psoriasis
Read More
AstraZeneca studies AZD-8871 for COPD in phase IIa trial
Read More
Lilly begins phase I study of LY-2775240
Read More
New phase II/III trial investigates Glassia for acute GvHD
Read More
Clovis initiates phase II trial of rucaparib for metastatic castration-resistant prostate cancer
Read More
Boehringer Ingelheim initiates phase I trial of BI-754091 in solid tumors
Read More
Lilly initiates first-in-human study of LY-3209590 for type 2 diabetes
Read More